Cardiovascular risk factors in psoriatic and rheumatoid arthritis


如何引用文章

全文:

详细

Aim. To study the role of conventional and new factors of cardiovascular risk in development of atherosclerosis in patients with rheumatoid arthritis (RA) and psoriatic arthritis (PA).
Material and methods. Sixty patients with psoriatic arthritis, 414 RA patients and 79 healthy controls entered the trial. All of them had no manifestations of cardiovascular diseases. Screening was made of the leading risk factors of cardiovascular diseases and cardiovascular complications, thickness of the complex intima-media (TIM) of the carotid arteries, vascular wall stiffness were measured, vasoregulatory function of the endothelium, markers of endothelial damage were examined.
Results. Patients with psoriatic and rheumatoid arthritis were found to have increased TIM of the carotid arteries, high incidence of atherosclerotic plaques, increased stiffness, damage of the vascular wall, affected endothelial vasoregulation. These alterations were associated with high arthritis activity, systemic manifestations, seropositivity by rheumatoid factor (in RA), presence of entesitis, uveitis and dactilitis (in psoriatic arthritis), dislipidemia, arterial hypertension (AH).
Conclusion. To determine cardiovascular risk in patients with arthritis, it is necessary to consider not only standard risk factors (dislipidemia and AH), but also severity of systemic inflammation, arterial stiffness, endothelial damage and ability of the vascular wall to relax reflecting endothelial dysfunction.

作者简介

Andrey Rebrov

Email: andreyrebrov@yandex.ru

Natal'ya Nikitina

Inna Gaydukova

A Rebrov

State Medical University, Saratov

State Medical University, Saratov

N Nikitina

State Medical University, Saratov

State Medical University, Saratov

I Gaidukova

Regional hospital, Saratov

Regional hospital, Saratov

参考

  1. Gladman D. D., Farewell V. T., Wong К. Mortality studies in psoriatic arthritis: results from a single outpatient center. Prognostic indicators for death. Arthr. and Rheum. l998; 41: 1103-1010.
  2. Maradit-Kremers H., Nicola P. J., Crowson C. S. et al. Cardiovascular death in rheumatoid arthritis: A population - based study. Arthr. and Rlieum 2005; 52:722-732.
  3. Gonzalez-Gay M. A., Gonzalez-Juanatey C., Martin X. Rheumatoid arthritis: The disease associated with accelerated atherogenesis. Semin. Arthr. Rheum. 2005; 35: 8-17.
  4. Del Rincon I. D., Williams K., Stern M. P. et al. High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors. Arthr. and Rheum. 2001; 44 (12): 2737-2745.
  5. Erb N. X., Banks M. J., Rowe I. F.et al. Unavoidable and modifiable risk factors for ischaemic heart disease (IHD) in rheumatoid arthritis (RA) (Abstr.) EULAR J. 2001; 60 (Suppl. 1): 18.
  6. Antivalle M., Mutti A., Randisi G. et al. Prevalence of metabolic syndrome, risk factor clustering, inflammatory markers, and cardiovascular morbidity in rheumatoid arthritis and spondyloarthritis. Ann. Rheum. Dis. 2006; 65 (Suppl. II): 160.
  7. McEntegart A., Capell H. A., Creran D. et al. Cardiovascular risk factors, including thrombotic variables, in a population with rheumatoid arthritis. Rheumatology 2001; 409 (6): 640- 644.
  8. Псориатический артрит. B кн.: Насонов Е. Л. (ред.). Клинические рекомендации. Ревматология. М.: ГЕОТАР-Медиа; 2005. 92-98.
  9. Олюнин Ю. А. Оценка активности и эффективности терапии ревматоидного артрита. В кн.: Международные индексы оценки активности, функционального статуса и качества жизни больных ревматическими заболеваниями. M.: Изд. группа "Ассоциации ревматологов России"; 2007. 3-12.
  10. Оганов Р. Г. Факторы риска сердечно-сосудистых заболеваний. В кн.: Оганов Р. Г., Фомина И. Г. Болезни сердца: Руководство для врачей. М: Литера; 2006. 35-53.
  11. Бадокин В. В. Псориатический артрит: клиника, диагностика, лечение: Автореф. дис. ... д-ра мед. наук. М., 2003.
  12. Hodis H. N., Mack W. J., LaBree L. et al. The role of carotid arterial intima-media thickness in predicting clinical coronary events. Ann. Intern. Med. 1998; 128 (4): 262-269.
  13. Lund L. Digital pulse plethysmography in studies of the haemodynamic response to nitrates: a survey of recording methods and principles of analysis. Acta Pharmacol. Toxicol. 1986; 59: 79-96.
  14. Парфенов А. С. Экспресс-диагностика сердечно-сосудистых заболеваний. Мир измерений 2006; 6: 74-82.
  15. Han С., Robinson D. W., Hackett M. V. et al. Cardiovascular disease and risk factors in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. J. Rheumatol. 2006; 33: 2167-2172.
  16. Jones S. M., Harris C. P. D., Lloyd J. et al. Lipoproteins and their subfractions in psoriatic arthritis: identification of an atherogenic profile with active joint disease. Ann. Rheum. Dis. 2000; 59 (5): 904-909.
  17. Neiman A. L., Shin D. В., Wang X. et al. Prevalence of cardiovascular risk factors in patients with psoriasis. J. Am. Acad. Dermatol. 2006; 55: 829-835.
  18. Бадокин В. В., Янышева А. В., Александрова Е. Н. и др. Риск развития сердечно-сосудистых заболеваний при псориатическом артрите. Тер. арх. 2009; 6: 41-47.
  19. Gisondi P., Tessari G., Conti A. et al. Prevalence of metabolic syndrome in patients with psoriasis: a hospital-based case-control study. Br. J. Dermatol. 2007; 157 (1): 68-73.
  20. Насонов Е. Л. Иммунологические вопросы атеросклероза. Тер. арх. 2002, 5: 80-85.
  21. Takazawa К., Tanaka N., Fujita M. Assessment of vasoactive agents and vascular aging by the second derivative of photoplethysmograph waveform. Hypertension 1998; 32: 365-370.
  22. Насонов Е. Л., Попкова Т. В. Кардиоваскулярные проблемы в ревматологии. Науч.-практ. ревматол. 2004; 1: 80- 85.
  23. Arnett D. K., Evans G. W., Riley W. A. Arterial stiffness: a nero-cardiovascular risk factor? Am. J. Epidemiol. 1994; 140: 669-682.
  24. Chen C. H., Nevo E., Fetics B. et al. Estimation of central aortic pressure waveform by mathematical transformation of radial tonometry pressure: validation of generalized transfer function. Circulation 1997; 95: 1827-1836.
  25. Kals J., Kampus P., Kals M. Arterial elasticity is associated with endothelial vasodilatory function and asymmetric dimethylarginine level in healthy subjects. Scand. J. Clin. Lab. Invest. 2007; 67: 536-544.

补充文件

附件文件
动作
1. JATS XML
下载

版权所有 © Consilium Medicum, 2011

Creative Commons License
此作品已接受知识共享署名-非商业性使用-相同方式共享 4.0国际许可协议的许可。
 

Address of the Editorial Office:

  • Alabyan Street, 13/1, Moscow, 127055, Russian Federation

Correspondence address:

  • Alabyan Street, 13/1, Moscow, 127055, Russian Federation

Managing Editor:

  • Tel.: +7 (926) 905-41-26
  • E-mail: e.gorbacheva@ter-arkhiv.ru

 

 © 2018-2021 "Consilium Medicum" Publishing house